Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma
Purpose. To compare the outcomes of Ex-PRESS glaucoma filtration device and transscleral cyclophotocoagulation (TSCP) in the management of neovascular glaucoma (NVG). Patients and Methods. A total of 30 eyes (12 express shunts and 18 TSCP) of 28 patients were included. The eyes had NVG with intraocu...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2020/3781249 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832556929565589504 |
---|---|
author | Faried Mohammed Wagdy Adel Galal Zaky |
author_facet | Faried Mohammed Wagdy Adel Galal Zaky |
author_sort | Faried Mohammed Wagdy |
collection | DOAJ |
description | Purpose. To compare the outcomes of Ex-PRESS glaucoma filtration device and transscleral cyclophotocoagulation (TSCP) in the management of neovascular glaucoma (NVG). Patients and Methods. A total of 30 eyes (12 express shunts and 18 TSCP) of 28 patients were included. The eyes had NVG with intraocular pressure (IOP) more than 21 mmHg of the maximally tolerated medication treatment after previous panretinal photocoagulation and antivascular endothelial growth factor (anti-VEGF) injection, with no previous history of a cyclodestruction procedure or glaucoma surgery, were randomized either for Ex-PRESS glaucoma filtration device or TSCP. The patients were followed up weekly for the first month and then monthly for 12 months as regard to the IOP, number of topical antiglaucoma drugs required, visual outcome, and postoperative complications. Results. IOP was successfully controlled with both techniques in 83.3% of the eyes. Both techniques had fewer complications and required fewer subsequent procedures. Conclusion. Both the Ex-PRESS glaucoma filtration device and TSCP might constitute safe and alternative therapeutic tools for patients with NVG. However, TSCP is an easier procedure, less time consuming, and does not require a learning curve. |
format | Article |
id | doaj-art-fb39659dd1cf42b5b57f1d240e8033ca |
institution | Kabale University |
issn | 2090-004X 2090-0058 |
language | English |
publishDate | 2020-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Ophthalmology |
spelling | doaj-art-fb39659dd1cf42b5b57f1d240e8033ca2025-02-03T05:44:13ZengWileyJournal of Ophthalmology2090-004X2090-00582020-01-01202010.1155/2020/37812493781249Comparison between the Express Implant and Transscleral Diode Laser in Neovascular GlaucomaFaried Mohammed Wagdy0Adel Galal Zaky1Ophthalmology Department, Faculty of Medicine, Menoufia University, Shebeen El-Kom, EgyptOphthalmology Department, Faculty of Medicine, Menoufia University, Shebeen El-Kom, EgyptPurpose. To compare the outcomes of Ex-PRESS glaucoma filtration device and transscleral cyclophotocoagulation (TSCP) in the management of neovascular glaucoma (NVG). Patients and Methods. A total of 30 eyes (12 express shunts and 18 TSCP) of 28 patients were included. The eyes had NVG with intraocular pressure (IOP) more than 21 mmHg of the maximally tolerated medication treatment after previous panretinal photocoagulation and antivascular endothelial growth factor (anti-VEGF) injection, with no previous history of a cyclodestruction procedure or glaucoma surgery, were randomized either for Ex-PRESS glaucoma filtration device or TSCP. The patients were followed up weekly for the first month and then monthly for 12 months as regard to the IOP, number of topical antiglaucoma drugs required, visual outcome, and postoperative complications. Results. IOP was successfully controlled with both techniques in 83.3% of the eyes. Both techniques had fewer complications and required fewer subsequent procedures. Conclusion. Both the Ex-PRESS glaucoma filtration device and TSCP might constitute safe and alternative therapeutic tools for patients with NVG. However, TSCP is an easier procedure, less time consuming, and does not require a learning curve.http://dx.doi.org/10.1155/2020/3781249 |
spellingShingle | Faried Mohammed Wagdy Adel Galal Zaky Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma Journal of Ophthalmology |
title | Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma |
title_full | Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma |
title_fullStr | Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma |
title_full_unstemmed | Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma |
title_short | Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma |
title_sort | comparison between the express implant and transscleral diode laser in neovascular glaucoma |
url | http://dx.doi.org/10.1155/2020/3781249 |
work_keys_str_mv | AT fariedmohammedwagdy comparisonbetweentheexpressimplantandtransscleraldiodelaserinneovascularglaucoma AT adelgalalzaky comparisonbetweentheexpressimplantandtransscleraldiodelaserinneovascularglaucoma |